LIC’s shareholding in Dr. Reddy’s Laboratories rose from 5.6% at the end of September 2024 to 6.5% by December 2024, and further to 7.19% as of March 2025, according to the latest shareholding ...

Dr Reddy’s Laboratories announced that it has partnered with Alvotech, to co-develop, manufacture, and sell a biosimilar version of Keytruda (pembrolizumab), for global markets.

Alvotech and Dr. Reddy's will share development, manufacturing, and commercialization responsibilities. Market-moving news hits Benzinga Pro first—get a 30-minute edge and save 60% this 4th of July.

CHENNAI: Shares of Dr Reddy’s Laboratories surged over 3% in early trade on Thursday after the Indian drug maker announced a global licensing agreement with Alvotech, an Iceland-based ...

Dr Reddy's Laboratories Ltd (NYSE:RDY) achieved record high revenue exceeding $3.8 billion and crossed the $1 billion threshold in EBITDA for the first time. The company reported a year-over-year ...

VIJAYAWADA: Former Defence Research and Development Organisation (DRDO) Chairman Dr G Satish Reddy officially assumed charge as Advisor for Aerospace and Defens ...

It requires the company to respond as to why notice should not be issued for the assessment of income alleged to be escaped from tax consequent to the merger of DRHL into Dr Reddy's Laboratories ...

Dr Reddy's Share Price Update — April 15 Amid the news, Dr Reddy's Labs shares are in focus today, on April 15. At 11.13 am, the stock was up 3 per cent or 33.30 points to ₹ 1,142.80 from open ...

Pharma major Dr. Reddy’s Laboratories has said that the Indian Income Tax Department served a show-cause notice on the company on April 4, asking it to explain why its IT returns for the ...

For context, Dr Reddy's R&D spending stood at 9.1 percent of total revenue in the July-September period, up from 8.1 percent in the previous quarter. In the first half of FY25, the company's R&D ...

Dr Reddy’s Laboratories (RDY) has released an update. Dr. Reddy’s Laboratories has expanded its global footprint by establishing a new wholly-owned subsidiary, Dr. Reddy’s Denmark ApS, in ...